Highstreet Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Highstreet Asset Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-18	Closed	-$2K	–	461
2019 Q2	$2K	Sell	18 -9	-33%	-$890	﹤0.01%	376
2019 Q1	$3K	Sell	27 -4,184	-99%	-$417K	﹤0.01%	343
2018 Q4	$356K	Sell	4,211 -1,732	-29%	-$167K	0.02%	234
2018 Q3	$584K	Buy	5,943 +588	+11%	+$63.6K	0.03%	204
2018 Q2	$620K	Buy	5,355 +1,122	+27%	+$123K	0.04%	186
2018 Q1	$418K	Sell	4,233 -1,632	-28%	-$165K	0.03%	186
2017 Q4	$614K	Buy	5,865 +2,244	+62%	+$247K	0.04%	173
2017 Q3	$408K	Buy	3,621 +1,441	+66%	+$157K	0.04%	187
2017 Q2	$244K	Buy	+2,180	New	+$246K	0.03%	188

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CAM

Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return

Highstreet Asset Management's TARO Position: Q3 2019 in Review

Highstreet Asset Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2019, closing a stake of 18 shares — an estimated $2K sold.

Highstreet Asset Management first reported a position in TARO in Q2 2017 and held it in 9 quarters. The position peaked at $620K in Q2 2018. 101 funds tracked by Wall St. Rank hold TARO as of Q3 2019.

Highstreet Asset Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2019 after selling out during the quarter.
Highstreet Asset Management sold 18 Taro Pharmaceutical Industries Ltd. shares in Q3 2019, an estimated $2K.
Highstreet Asset Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2017 and held it in 9 quarters.
Highstreet Asset Management's Taro Pharmaceutical Industries Ltd. position peaked at $620K in Q2 2018.
101 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2019.

Based on Highstreet Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.